Evidence map›Paper›PMID 40734576›Full record

ArticleEpidemiology and infection2025

Hepatitis B susceptibility and subsequent vaccination in priority populations across an Australian sentinel surveillance network, 2017

Leila Bell, Virginia Pilcher, Elly Layton, Victoria Polkinghorne, Jason Asselin, Anna Wilkinson, Joseph Doyle, Phillip Read, Mish Pony, Stella Pendle and 5 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Leila BellDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.ORCID 0000-0002-7900-3612
Virginia PilcherDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Elly LaytonDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Victoria PolkinghorneDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Jason AsselinDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Anna WilkinsonDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.ORCID 0000-0002-4475-5224
Joseph DoyleDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Phillip ReadSexual Health and Blood Borne Virus Services, South Eastern Sydney Local Health District, NSW Health, NSW, Australia.
Mish PonyScarlet Alliance, Australian Sex Workers Association, Newtown, NSW, Australia.
Stella PendleMicrobiology Department, Australian Clinical Labs, Bella Vista, NSW, Australia.
Wayne DimechScientific and Business Relations, National Reference Laboratory, Melbourne, VIC, Australia.
Mark StoovéDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Basil DonovanKirby Institute, https://ror.org/03r8z3t63University of New South Wales, Sydney, NSW, Australia.
Jessica HowellDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.
Margaret E HellardDisease Elimination, https://ror.org/05ktbsm52Burnet Institute, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus vaccination is currently recommended in Australia for adults at an increased risk of acquiring infection or at high risk of complications from infection. This retrospective cohort study used data from an Australian sentinel surveillance system to assess the proportion of individuals who had a recorded test that indicated being susceptible to hepatitis B infection in six priority populations, as well as the proportion who were then subsequently vaccinated within six months of being identified as susceptible. Priority populations included in this analysis were people born overseas in a hepatitis B endemic country, people living with HIV, people with a recent hepatitis C infection, gay, bisexual and other men who have sex with men, people who have ever injected drugs, and sex workers. Results of the study found that in the overall cohort of 43,335 individuals, 14,140 (33%) were identified as susceptible to hepatitis B, and 5,255 (37%) were subsequently vaccinated. Between 26% and 33% of individuals from priority populations were identified as susceptible to hepatitis B infection, and the proportion of these subsequently vaccinated within six months was between 28% and 42% across the groups. These findings suggest further efforts are needed to increase the identification and subsequent vaccination of susceptible individuals among priority populations recommended for hepatitis B vaccination, including among people who are already engaged in hepatitis B care.

Indexed as

Hepatitis BHepatitis B VaccinesVaccinationAdolescentAdultAgedAustraliaDisease SusceptibilityFemaleHepatitis B virusHumansMaleMiddle AgedRetrospective StudiesSentinel SurveillanceYoung AdultHepatitis B Vaccineshepatitis B susceptibilityhepatitis B vaccinationhepatitis B viruspriority populationssentinel surveillance systemvaccination coverage

Identifiers

PMID40734576
PMCPMC12308616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.